The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast

• Published in: Human pathology 2012, Vol.43 (1), p.48-55
• Main Authors: Choi, Yoomi, MD, Kim, Eun Joo, Seol, Hyesil, MD, Lee, Hee Eun, MD, PhD, Jang, Mi Jung, MD, Kim, Sun Mi, MD, PhD, Kim, Jee Hyun, MD, PhD, Kim, Sung-Won, MD, PhD, Choe, Gheeyoung, MD, PhD, Park, So Yeon, MD, PhD
• Format: Article
• Language: English
• Subjects: Adult; Aged; Biological and medical sciences; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Breast cancer; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Carcinoma, Ductal, Breast - genetics; Carcinoma, Ductal, Breast - metabolism; Carcinoma, Ductal, Breast - pathology; Cell Nucleus - genetics; Cell Nucleus - metabolism; Cell Nucleus - pathology; DNA, Neoplasm - analysis; Female; Gynecology. Andrology. Obstetrics; HER-2; Hormone receptor; Humans; In Situ Hybridization, Fluorescence; Investigative techniques, diagnostic techniques (general aspects); Mammary gland diseases; Mastectomy; Medical sciences; Middle Aged; Neoplasms, Multiple Primary - genetics; Neoplasms, Multiple Primary - metabolism; Neoplasms, Multiple Primary - pathology; Pathology; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques; Phenotype; Receptor, ErbB-2 - genetics; Receptor, ErbB-2 - metabolism; Receptors, Steroid - genetics; Receptors, Steroid - metabolism; Tissue Array Analysis; Tumors; Young Adult
• ISSN: 0046-8177; 1532-8392
• DOI: 10.1016/j.humpath.2010.08.026

Summary Multifocal/multicentric breast cancers are common. However, investigations of biomarkers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 in individual tumor foci of such cancers are rare. This study was designed to evaluate the status of the hormone receptors, human epidermal growth factor receptor 2, and its molecular subtypes in individual foci of multifocal/multicentric invasive ductal carcinoma of the breast and to identify the factors associated with the different phenotypes of individual foci. We performed immunohistochemical analyses of the estrogen receptor, progesterone receptor, cytokeratin 5/6, epidermal growth factor receptor, and p53 and fluorescence in situ hybridization of human epidermal growth factor receptor 2 in individual foci of 65 cases of multifocal/multicentric invasive ductal carcinoma and the associated ductal carcinoma in situ components using tissue microarrays. The estrogen receptor status differed in 2 (3%) of the 65 invasive ductal carcinomas, progesterone receptor status in 7 (11%), human epidermal growth factor receptor 2 status in 4 (6%), and molecular subtypes in 5 (8%). The presence of different molecular subtypes in the invasive tumor foci was associated with differences in histologic features ( P = .005), high histologic and nuclear grade ( P = .012 and P = .021, respectively), p53 overexpression ( P = .006), and mixed molecular subtypes in the ductal carcinoma in situ components ( P = .011). Multifocal/multicentric invasive ductal carcinomas usually have a single phenotype in terms of hormone receptors, human epidermal growth factor receptor 2, and molecular subtypes; and thus, immunohistochemical analyses of the index tumor may be sufficient in routine practice. However, if multifocal/multicentric invasive ductal carcinomas are of high grade, of different histologic features, or of heterogeneous ductal carcinoma in situ component, biomarkers of the various foci need to be evaluated separately.